Comparative Study of Videolaryngostroboscopic Findings and Voice Handicap Index Before and After Treatment in Patients Presenting with Hoarseness Due to Non Malignant Lesions

A comparative study on the collecting effect to cassiterite was studied using a new carboxylic acid modified collector DXS and traditional collector salicylaldehyde hydroxamic acid as collectors, respectively. In addition, the relationship between floatability of DXS and crystal structure of cassiterite was investigated. By means of infrared spectroscopy analysis of the cassiterite surface before and after adsorbing DXS molecules, the adsorption mechanisms of DXS on the surface of cassiterite were analyzed.Keywords: carboxylic acid modified collector DXS; cassiterite; flotation mechanism

Download Full-text

Growth, Inequality, and Poverty: A Comparative Study of China's Experience in the Periods before and after the Asian Crisis

Inequality and Public Policy in China ◽

10.1017/cbo9780511510922.006 ◽

2009 ◽

pp. 145-181 ◽

Cited By ~ 8

Author(s):

Azizur Rahman Khan

Keyword(s):

Comparative Study ◽

Asian Crisis ◽

Before And After

Download Full-text

Comparison of the Efficacy, Safety and Tolerability of Azithromycin and Co-Amoxiclav in the Treatment of Acute Periapical Abscesses

Journal of International Medical Research ◽

10.1177/030006059802600506 ◽

1998 ◽

Vol 26 (5) ◽

pp. 257-265 ◽

Cited By ~ 15

Author(s):

CF Adriaenssen

Keyword(s):

Soft Tissue ◽

Adverse Events ◽

Comparative Study ◽

Clinical Success ◽

Point Scale ◽

Once Daily ◽

Significant Difference ◽

Before And After ◽

Dental Practices

The activity, safety and tolerability of the azalide azithromycin were compared with those of co-amoxiclav in the treatment of acute periapical abscesses in adults in an open, randomized, multicentre comparative study. Patients of either sex, recruited from 106 dental practices in Belgium, were aged between 18 and 75 years and had acute periapical abscesses not requiring drainage, confirmed by radiology. Azithromycin was administered as a 500-mg tablet orally once daily for 3 days ( n = 150) and co-amoxiclav as a 625-mg capsule three times daily, for 5–10 days ( n = 153). Both before and after treatment, masticatory pain, percussion pain, headache, and oedema and redness of soft tissue were graded on a four-point scale. Overall clinical success (cure plus improvement) was seen in 131/144 (91%) evaluable patients receiving azithromycin and in 142/148 (96%) receiving co-amoxiclav (difference not significant). There was no significant difference between the two groups in the incidence or severity of adverse events or in the number of discontinuations because of adverse events.

Download Full-text